Meticulous Research®, a renowned leader in the field of market research, has recently published its comprehensive report titled “Plasmapheresis Market by Product (Instruments, Disposables), Technology (Membrane Filtration, Centrifugation), Application (Therapeutic [Immunology, Neurology, Hematology], Plasma Collection), End User (Biopharma, Hospitals) - Global Forecast to 2030.” According to the report, the global plasmapheresis market is expected to reach approximately $2.55 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030.
Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=3092?
This growth is attributed to several factors, including the rising prevalence of autoimmune diseases, an increasing demand for source plasma from biopharmaceutical companies, and favorable reimbursement policies that support plasmapheresis procedures. Additionally, the growing need for plasmapheresis in emerging markets offers promising growth opportunities. However, the market faces certain challenges, such as the high costs associated with plasmapheresis devices and procedures, as well as potential risks related to the procedures themselves. Furthermore, limited awareness and access to plasmapheresis services in specific regions are expected to impede market growth.
Market Overview and Segmentation
The plasmapheresis market is categorized into several segments based on product, technology, application, end-user, and geography. On the product front, the market includes instruments and disposables, while technology is divided into membrane filtration and centrifugation. Applications range from therapeutic uses in immunology, neurology, and hematology to plasma collection for biopharmaceutical purposes. The end users of plasmapheresis procedures include biopharmaceutical companies, hospitals, and other healthcare providers.
From a product perspective, the disposable segment is projected to dominate the market share in 2023. This is primarily due to the continuous demand for plasma separation filters and administration sets required for plasmapheresis procedures, which are considered essential consumables.
In terms of technology, the centrifugation segment is expected to capture the largest share of the market in 2023, owing to its efficiency in rapidly separating plasma from blood components. Centrifugation technology has become widely adopted in plasmapheresis due to its precision, speed, and effectiveness in plasma extraction.
On the application side, the source plasma collection segment is anticipated to hold the largest market share in 2023. This growth is driven by increased demand from pharmaceutical and biotechnology companies for source plasma used in producing life-saving plasma-derived therapies. Additionally, growing awareness and participation in voluntary plasma donation programs have significantly contributed to the expansion of this segment.
Regarding the end-user perspective, the source plasma collection sector is expected to account for the largest share of the market in 2023. The demand for source plasma, necessary for producing plasma-based products through fractionation, has surged, particularly in the pharmaceutical and biotechnology industries.
Regional Insights
The report provides an in-depth analysis of the plasmapheresis market across various key regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Among these regions, North America is expected to lead the market in 2023, driven by increased awareness of the therapeutic benefits of plasmapheresis, high prevalence of autoimmune diseases, rapid technological advancements, and the presence of a robust healthcare system.
Europe is expected to follow North America in market share, with countries such as Germany, France, the U.K., and Italy playing significant roles in driving regional growth. The Asia-Pacific region, particularly Japan, China, and India, is also projected to witness substantial growth due to the increasing adoption of plasmapheresis procedures and rising healthcare investments in these nations.
Key Market Players
The plasmapheresis market is highly competitive, with several major players operating globally. Key companies driving innovation and growth in the market include Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), SB-Kawasumi Laboratories, Inc. (Japan), Kaneka Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland). These companies are focusing on expanding their product portfolios, adopting technological advancements, and exploring strategic partnerships to maintain their competitive edge.
Buy Now: https://www.meticulousresearch.com/Checkout/79432394?
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research